Health Nov 06 The potential impact of lowering the cost of weight loss drugs By William Brangham, Jackson Hudgins, Jenna Bloom
Health Jun 29 Watch 6:15 New book by former FDA head explores the science behind GLP-1 weight loss drugs According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs containing GLP-1, a hormone that slows digestion and helps with sustained weight loss. In a new book,… By Ali Rogin, Zoie Lambert
Health Apr 14 Pfizer abandons potential obesity treatment pill The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials experienced a possible drug-induced liver injury that ended once the person stopped taking the treatment. By Tom Murphy, Associated Press
Health Jan 02 Watch 6:00 As weight loss drug demand soars, physician outlines effectiveness and potential downsides For weight loss drugs like Ozempic and Wegovy, 2024 was a big year. More patients are relying on them to manage their weight, treat diabetes, or prevent heart attacks and strokes. And while they are highly effective, they also come… By William Brangham, Jackson Hudgins, Hamada Hanoura
Health Oct 26 Watch 8:07 Why more doctors are treating children and adolescents with weight loss drugs Physicians are increasingly using weight loss drugs to treat obesity, diabetes and other chronic conditions in young patients. In the last three years, the number of people between the ages of 12 and 25 using drugs like Wegovy and Ozempic… By Ali Rogin, Satvi Sunkara
Sep 24 Watch 3:57 Lawmakers challenge drug company CEO over steep prices for Ozempic and Wegovy By William Brangham, Courtney Norris, Ryan Connelly Holmes Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes and obesity. But the drugs are extremely expensive, and the drugmaker’s CEO appeared on Capitol Hill Tuesday to face… Continue watching
Jun 17 Watch 8:38 The many ways new weight loss drugs could transform the economy By Catherine Rampell, Diane Lincoln Estes Last year, Americans spent over $50 billion on weight loss drugs like Ozempic and Wegovy. Their popularity, and their price, are having effects throughout the economy. PBS News Hour special correspondent and Washington Post columnist Catherine Rampell reports. Continue watching
Dec 28 Watch 7:59 Physician discusses surge in demand for weight-loss drugs and risks in using them By Ali Rogin, Karina Cuevas One of the biggest health stories of this past year is the surge in demand for popular weight-loss drugs like Ozempic and Wegovy. Those drugs are in such demand that there’s a nationwide shortage of them. Pharmaceutical companies are scrambling… Continue watching
Dec 28 Why new weight loss drugs are out of reach for millions of older Americans By Amanda Seitz, Associated Press Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds. But those drugs remain out of reach for millions of older Americans. Continue reading
Nov 11 Study published that finds obesity drug Wegovy lowers risk of serious heart problems By JoNel Aleccia, Associated Press The popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20 percent in a large, international study that experts say could change the way doctors treat certain heart patients. Continue reading